By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Lab21 has licensed worldwide rights to a suite of patents from Cooperative Diagnostics covering real-time PCR technology that the firm will incorporate into molecular diagnostic kits.

The Cambridge, UK-based diagnostic products and services firm said that as part of the agreement it has exclusive use of the technology on a set of biomarker targets for the oncology and infectious disease areas. Financial and other terms of the pact were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.